Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 mTOR inhibitors and sorafenib for recurrent heptocellular carcinoma after orthotopic liver transplantation.

× No keyword cloud information.

10 in total

Review 1. Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.

Authors: Nicola de'Angelis; Filippo Landi; Maria Clotilde Carra; Daniel Azoulay
Journal: World J Gastroenterol Date: 2015-10-21 Impact factor: 5.742

2. Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma.

Authors: Sung-Hwa Kang; Shin Hwang; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Gil-Chun Park; Bo-Hyun Jung; Young-In Yoon; Sung-Gyu Lee
Journal: Korean J Hepatobiliary Pancreat Surg Date: 2014-05-31

Review 3. Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence.

Authors: Shirin Elizabeth Khorsandi; Nigel Heaton
Journal: Transl Gastroenterol Hepatol Date: 2016-04-06

Review 4. Liver transplantation for hepatocellular carcinoma.

Authors: M Katherine Rude; Jeffrey S Crippin
Journal: Curr Gastroenterol Rep Date: 2015-03

Review 5. Progress in the treatment of pulmonary metastases after liver transplantation for hepatocellular carcinoma.

Authors: Zhan-Wang Xiang; Lin Sun; Guo-Hong Li; Rakesh Maharjan; Jin-Hua Huang; Chuan-Xing Li
Journal: World J Hepatol Date: 2015-09-18

Review 6. Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence.

Authors: Robert S Rahimi; James F Trotter
Journal: Ann Gastroenterol Date: 2015 Jul-Sep

7. Use of adjuvant sorafenib in liver transplant recipients with high-risk hepatocellular carcinoma.

Authors: Kirti Shetty; Chiranjeev Dash; Jacqueline Laurin
Journal: J Transplant Date: 2014-04-10

Review 8. Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma.

Authors: Carlo Sposito; Davide Citterio; Matteo Virdis; Carlo Battiston; Michele Droz Dit Busset; Maria Flores; Vincenzo Mazzaferro
Journal: World J Gastroenterol Date: 2022-09-14 Impact factor: 5.374

9. Scientometric analysis of mTOR signaling pathway in liver disease.

Authors: Jing Fang; Long Pan; Qiu-Xia Gu; Sarun Juengpanich; Jun-Hao Zheng; Chen-Hao Tong; Zi-Yuan Wang; Jun-Jie Nan; Yi-Fan Wang
Journal: Ann Transl Med Date: 2020-02

10. The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation.

Authors: Matteo Ravaioli; Alessandro Cucchetti; Antonio Daniele Pinna; Vanessa De Pace; Flavia Neri; Maria Aurelia Barbera; Lorenzo Maroni; Giorgio Frega; Andrea Palloni; Stefania De Lorenzo; Maria Cristina Ripoli; Maria Abbondanza Pantaleo; Matteo Cescon; Massimo Del Gaudio; Giovanni Brandi
Journal: Sci Rep Date: 2017-09-12 Impact factor: 4.379

10 in total